Literature DB >> 2967740

Measurement and characterization of angiotensin peptides in plasma.

K Hermann1, D Ganten, T Unger, C Bayer, R E Lang.   

Abstract

We report a method for the extraction of angiotensin peptides from plasma with a mixture of acetone, 1 mol/L HCl, and water (40/1/5 by vol). The method is highly reproducible for the measurement of angiotensin I and angiotensin II in small sample volumes, with analytical recoveries of about 80% for both peptides. We investigated the influence of sample handling and found a standard procedure for blood collection, plasma preparation, and extraction was essential. The method was used to measure angiotensin I and II in rat and human plasma. In rat plasma, the mean (+/- SEM) concentrations of angiotensin I and angiotensin II were determined to be 67 (+/- 8) and 14 (+/- 1) pmol/L (n = 10), respectively. Neither angiotensin I nor angiotensin II was detectable 24 h after bilateral nephrectomy. Acute oral administration of the converting-enzyme inhibitor ramipril caused a significant increase of angiotensin I from 85 (+/- 6) to 257 (+/- 33) pmol/L (n = 10; P less than 0.001) and a significant decrease of angiotensin II from 12 (+/- 1) to 7 (+/- 0.4) pmol/L in rat plasma (n = 9; P less than 0.001). In human plasma, angiotensin I and angiotensin II values of 21 (+/- 1) and 6.6 (+/- 0.5) pmol/L (n = 10) were found. A single oral dose of the diuretic furosemide increased angiotensin I significantly from 21 (+/- 1) to 32 (+/- 1.7) pmol/L (n = 5); P less than 0.001), whereas angiotensin II remained unchanged, 6.6 (+/- 0.5) vs 6.4 (+/- 0.4) pmol/L (n = 5). Extracted peptides could be identified as [IIe5]-angiotensin I and [IIe5]-angiotensin II by HPLC in combination with specific radioimmunoassays for angiotensin I and angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967740

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.

Authors:  J Peters; K Münter; M Bader; E Hackenthal; J J Mullins; D Ganten
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes.

Authors:  D Ganten; J Wagner; K Zeh; M Bader; J B Michel; M Paul; F Zimmermann; P Ruf; U Hilgenfeldt; U Ganten
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts.

Authors:  Heike Wanka; Nicole Kessler; Janett Ellmer; Nicole Endlich; Barbara S Peters; Susanne Clausmeyer; Jörg Peters
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

5.  Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats.

Authors:  Swapna Upadhyay; Tobias Stoeger; Leema George; Mette C Schladweiler; Urmila Kodavanti; Koustav Ganguly; Holger Schulz
Journal:  Part Fibre Toxicol       Date:  2014-09-17       Impact factor: 9.400

6.  Spinal cord injury increases the reactivity of rat tail artery to angiotensin II.

Authors:  Hussain Al Dera; James A Brock
Journal:  Front Neurosci       Date:  2015-01-06       Impact factor: 4.677

7.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

8.  Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats.

Authors:  Swapna Upadhyay; Tobias Stoeger; Volkar Harder; Ronald F Thomas; Mette C Schladweiler; Manuela Semmler-Behnke; Shinji Takenaka; Erwin Karg; Peter Reitmeir; Michael Bader; Andreas Stampfl; Urmila P Kodavanti; Holger Schulz
Journal:  Part Fibre Toxicol       Date:  2008-12-04       Impact factor: 9.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.